Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G9XP
|
||||
Former ID |
DCL001205
|
||||
Drug Name |
LB80380
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | HBV infection [ICD9: 070.2-070.3; ICD10:B16, B18.0, B18.1] | Phase 2b | [551083] | ||
Company |
LG Life Sciences
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H34N5O8P
|
||||
Canonical SMILES |
CC(C)(C)C(=O)OCOP(=O)(COC1(CC1)CN2C=NC3=CN=C(N=C32)N)OC<br />OC(=O)C(C)(C)C
|
||||
InChI |
1S/C22H34N5O8P/c1-20(2,3)17(28)31-12-34-36(30,35-13-32-18(29)21(4,5)6)14-33-22(7-8-22)10-27-11-25-15-9-24-19(23)26-16(15)27/h9,11H,7-8,10,12-14H2,1-6H3,(H2,23,24,26)
|
||||
InChIKey |
JLKJXDOWBVVABZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | DNA polymerase/reverse transcriptase | Target Info | Inhibitor | [551083] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.